French health technology company Volta Medical has partnered with US-based GE HealthCare to combine their AI-powered electrophysiology technologies to improve arrhythmia procedures.

Under the collaboration, Volta will integrate its latest AI solution, Volta AF-Xplorer, with GE HealthCare’s Prucka 3 digital platform and CardioLab EP Recording system.

The combined solutions are expected to enhance performance and simplify workflows for electrophysiologists during catheter ablation procedures to treat atrial fibrillation (AFib).

Volta Medical CEO and co-founder Théophile Mohr-Durdez said: “Our mission to combat complex heart rhythm diseases relies on optimising interoperability.

“Through this collaboration with GE HealthCare, we are advancing the frontier of current clinical applications in the field of electrophysiology.

“To help enhance patient care in this field, Volta Medical aims to further integrate its AI solution with EP innovators to help increase compatibility and address the challenges clinicians face in analysing cardiac electrical signals.”

Volta Medical’s AI solution is designed to help electrophysiologists evaluate dispersed electrograms (EGMs) in real time.

The system’s performance aligns with the signal clarity offered by GE HealthCare’s CardioLab EP Recording system.

The collaboration aims to help physicians optimise AFib management by integrating advanced EP recording capabilities with AI-driven dispersion information.

Volta said the partnership builds on positive results for AI-guided ablation from the TAILORED-AF trial, presented at the Heart Rhythm Society 2024 meeting.

Currently, the company is focused on early commercialisation and completing the RESTART clinical trial of its AI ablation solution in recurrent-AF patients who failed previous ablations.

GE HealthCare invasive cardiology global GM Devon Bream said: “Access to vast amounts of data empowers clinicians in their decision-making, but effectively using this data at the point of care can be challenging.

“As GE HealthCare continues to advance our innovation to provide clinicians with precise signals in the EP lab, Volta Medical’s AI-driven solutions hold promise in consolidating and simplifying data, as well as assisting clinicians in making treatment decisions for their patients.

“I’m excited about our ongoing collaboration with Volta Medical as we work to innovate and transform electrophysiology labs to ensure patients receive the best possible care.”